2026 NPPES data Pharmacotherapy Pharmacist NPI 1033441332 PHD
Verify on CMS →

MAYRAM ABRAMOV, PHD

Pharmacotherapy Pharmacist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
85
Medicare Part D claims · 76 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
1%
generic claims · 99% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MAYRAM ABRAMOV, PHD is a Pharmacotherapy Pharmacist ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 85 claims across 76 beneficiaries — 99% brand-name prescribing .

What stands out: MAYRAM ABRAMOV, PHD filed 85 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MAYRAM ABRAMOV, PHD at a glance

Quality data not reported

NPI registry status

Active

Issued 02/11/2010

NPI 1033441332

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

85 79% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in New York

How Pharmacotherapy Pharmacist compares to other specialties among New York providers

New York providers

Pharmacotherapy Pharmacist share within New York

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAYRAM ABRAMOV, PHD is a Pharmacotherapy Pharmacist provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHD. NPI: 1033441332. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MAYRAM ABRAMOV, PHD appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHD credentials at 773 LEXINGTON AVE, NEW YORK, NY, 10065, with a listed phone of (347) 622-2946. NPI 1033441332 was issued on 02/11/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABRAMOV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 85 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $21K in drug spend, split 99% brand-name and 1% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

773 LEXINGTON AVE
NEW YORK, NY 10065

Provider Details

NPI 1033441332
Specialty Pharmacotherapy Pharmacist
Credentials PHD
Gender Female
NPI Issued 02/11/2010

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MAYRAM ABRAMOV, PHD. To verify MAYRAM ABRAMOV, PHD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MAYRAM ABRAMOV, PHD — brand share 99.0%
Specialty average (est.)

99% brand-name claims vs 1% generic, on 85 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

85
Total Claims
$21K
Total Drug Cost
76
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
87
Total Day Supply
174
Brand vs Generic
99% brand / 1% generic
Brand Drug Cost
$21K

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
0.93
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Arexvy
Rsvpref3 Antigen/As01e/Pf
44
Shingrix
Varicella-Zoster Ge/As01b/Pf
30

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How MAYRAM ABRAMOV, PHD fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

MAYRAM ABRAMOV, PHD's 85 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ABRAMOV.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAYRAM ABRAMOV, PHD's specialty?
MAYRAM ABRAMOV, PHD specializes in Pharmacotherapy Pharmacist and practices in NEW YORK, New York. Credentials: PHD.
How much does MAYRAM ABRAMOV, PHD prescribe under Medicare Part D?
In 2023, MAYRAM ABRAMOV, PHD wrote 85 Medicare Part D claims totaling $21K in drug costs for 76 beneficiaries.
Where is MAYRAM ABRAMOV, PHD located?
MAYRAM ABRAMOV, PHD is located at 773 LEXINGTON AVE, NEW YORK, NY, 10065. Phone: (347) 622-2946.
What is MAYRAM ABRAMOV, PHD's NPI number?
MAYRAM ABRAMOV, PHD's National Provider Identifier (NPI) is 1033441332, issued on 02/11/2010.
Does MAYRAM ABRAMOV, PHD prescribe more brand-name or generic drugs?
MAYRAM ABRAMOV, PHD's prescribing is 99% brand-name and 1% generic drugs by claim count, with $21K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does MAYRAM ABRAMOV, PHD prescribe most often?
Based on 2023 Medicare Part D data, MAYRAM ABRAMOV, PHD's most frequently prescribed drugs include Arexvy, Shingrix. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAYRAM ABRAMOV, PHD accept Medicare?
MAYRAM ABRAMOV, PHD appears in CMS Medicare data with 85 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAYRAM ABRAMOV, PHD's credentials?
MAYRAM ABRAMOV, PHD's NPI is 1033441332 with credentials PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology